As iron goes, so goes disease?

Haematologica

Volumn 96, Issue 11, 2011, Pages 1571-1572

  Hayflick, Susan J ^a   Hogarth, Penelope ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERIPRONE; DEFEROXAMINE MESYLATE; IRON;

ACERULOPLASMINEMIA; BASAL GANGLION; CHELATION THERAPY; DISEASE COURSE; DISEASE SEVERITY; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; FATTY ACID HYDROXYLASE ASSOCIATED NEURODEGENERATION; HOMEOSTASIS; HUMAN; IRON OVERLOAD; KUFOR RAKEB DISEASE; MITOCHONDRIAL MEMBRANE PROTEIN ASSOCIATED NEURODEGENERATION; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NEUROFERRITINOPATHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION; PATHOGENESIS; PATHOPHYSIOLOGY; PHOSPHOLIPASE A2 ASSOCIATED NEURODEGENERATION; WOODHOUSE SAKATI SYNDROME;

FEMALE; HUMANS; IRON; IRON CHELATING AGENTS; IRON METABOLISM DISORDERS; MALE; NEURODEGENERATIVE DISEASES; PYRIDONES;

EID: 80355138252     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.055335     Document Type: Editorial

References (6)

1. Dooling EC, Schoene WC, Richardson EP Jr. Hallervorden-Spatz syndrome. Arch Neurol. 1974;30(1):70-83.
2. Gregory A, Polster BJ, Hayflick SJ. Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J Med Genet. 2009;46(2):73-80.
3. Gregory A, Hayflick SJ. Genetics of neurodegeneration with brain iron accumulation. Curr Neurol Neurosci Rep. 2011;11(3):254-61.
4. Abbruzzese G, Cossu G, Balocco M, Marchese R, Murgia D, Melis M, et al. A pilot trial of deferiprone for neurodegeneration with brain iron accumulation. Haematologica. 2011 Jul 26. [Epub ahead of print]
5. Forni GL, Balocco M, Cremonesi L, Abbruzzese G, Parodi RC, Marchese R. Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation. Mov Disord. 2008;23(6):904-7.
6. Zorzi G, Zibordi F, Chiapparini L, Bertini E, Russo L, Piga A, et al. Ironrelated MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: Results of a phase II pilot trial. Mov Disord. 2011;26(9):1755-9.